Nightly News
| September 19, 2012
Dr: New MS drug a ‘big step in the right direction’
Dr. Robert Fox, a neurologist at the Cleveland Clinic who headed the BG-12 study, says the drug is not a cure for MS, but it is well tolerated and helps decrease new lesions.